Gallagher Duncan

Director at HCAT

Sold, on record
$63k
Dollars the filings state
Form 4 sales
2
Latest Dec 30, 2024
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • HCATHealth Catalyst, Inc.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice HCATNotice
    Dec 23, 2024 2024

    Filed to sell 4,500 shares ($32k)

    Gallagher Duncan, Director

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale HCATRoutine
    Dec 23, 2024 same day

    Sold 4,500 shares at $6.98 ($31k)

    Gallagher Duncan, Director

    10b5-1 planSold 5.7% of holdings ($551k position)74,438 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice HCATNotice
    Dec 30, 2024 +7 days

    Filed to sell 4,500 shares ($32k)

    Gallagher Duncan, Director

    10b5-1 planFiling

  4. 4 Form 4 sale HCATRoutine
    Dec 30, 2024 same day

    Sold 4,500 shares at $6.93 ($31k)

    Gallagher Duncan, Director

    10b5-1 planSold 6% of holdings ($516k position)69,938 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Gallagher Duncan
Source
Dec 30, 2024Jan 2, 2025HCATDirectorForm 4 sale4,500$31k6.0%RoutineSEC
Dec 30, 2024Dec 30, 2024HCATDirectorForm 144 notice4,500$32kNoticeSEC
Dec 23, 2024Dec 27, 2024HCATDirectorForm 4 sale4,500$31k5.7%RoutineSEC
Dec 23, 2024Dec 23, 2024HCATDirectorForm 144 notice4,500$32kNoticeSEC